George Papandreou - General Manager and Senior Vice President, Focal Therapies at Orchestra BioMed Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Manager and Senior Vice President, Focal Therapies
Issuer Symbol
OBIO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by George Papandreou since 05 Jan 2025

Holdings reported by George Papandreou for Orchestra BioMed Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.0001 per share ("Common Stock") 42,000 $21,600 $1.08 08 May 2024 Direct
Stock Option (Right to Buy) 33,000 08 May 2024 Direct Common Stock $33,000

Transactions reported by George Papandreou for Orchestra BioMed Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.